Search

everythinglearnresearchcommunity

for

Search:↓

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Finasteride treats hair loss but may cause low libido, erectile issues, and depression.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride use can cause lasting negative effects like sexual dysfunction, depression, anxiety, and cognitive issues.

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Finasteride may cause depression and suicidal thoughts, especially in young men.

Acupuncture may help with hair regrowth in alopecia areata, but more research is needed.

Finasteride use may increase depression and suicide risk, especially at 1 mg, so monitoring is advised.

Finasteride helps hair growth in men but can cause side effects like decreased libido.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Topical finasteride is an effective and safer treatment for male hair loss.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.